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Lymphokine was tested for fungal growth inhibitory 
activity against the filamentous fungus Trichophyton 
mentagrophytes. Human p eripheral blood lymphocytes 
from a donor exhibiting d elaye d type cutaneous h y per-
sensitivity to a trichophytin skin test were cultured with 
trichophytin and PHA-P. Culture supernatants were as-
sayed for lymphokine activity u sing the lymphotoxin 
sensitive mouse L-929 a lpha fibroblast. Lymphocyte ac-
tivation to PHA-P and trichophytin was confirmed by 
monitoring :)H-thymidine incorporation. Supernatants 
from 2-day PHA-P and 6-day trichophytin activated cul-
tures were found to contain potent lymphokine activity. 
This activity was not diminished by the addition of ferric 
iron sufficient to saturate the contained transferrin. Su-
pernatants from unstimulated control cultures con-
tained no lymphokine activity. Undiluted lymphokine 
containing supernatants and nonlymphokine containing 
control supernatants were evaluated for fungal growth 
inhibitory activity using a sensitive radiometric growth 
assay. Iron s upplemented supernatants retaining potent 
lyxnphokine activity did not inhibit fungal growth. Non-
iron supplemented supernatants and fresh m edium con-
taining serum inhibite d fungal growth. Our data suggest 
t hat lymphokine active against mammalian cells is not 
directly antagonistic to the growth of the filamentous 
fungus T. mentagrophytes but does not exclude the pos-
sibility that activated lymphocytes release a chelator 
such as transferrin that can inhibit fungal growth. 
An acute inflammatory reaction correlates with the limitation 
of spread a nd eventual hea ling of experimentally induced der-
matophyte infections in man [1] a nd guinea pigs [2,3]. This 
inflammation is thought to be cell mediated since a temporal 
correlation exists between the appealfance of inflammation a nd 
t h e development of delayed type c~taneous hypersensitivity 
DR [1] and lymphocyte blastogenesis [3] elicited with tricho-
phytin antigen. Additionally , the presence of DH to trichophy-
t in was shown to correlate with the infection-fi'ee status of a 
large group of adult human ma les studied for evidence of 
dermatophytosis [4]. These observations suggest that cell me-
diated immunity, CMI, is involved in host defense against 
dermatophytes. The mechanism(s) whereby CM! may mediate 
host defense in this instance, however , remains unknown. 
The dermatophytes colonize the dead upper keratinized lay -
ers of the epidermis [5]. These layers are essentially extracor-
pora! and not normally exposed to the internal milieu of the 
host. That the cellular components of cutaneously expressed 
CMI reaction could come in contact with the fungus, much less 
survive in the environment of the skin surface and directly 
combat fungal growth, is very unlikely. 
On the other ha nd lymphokines, the effector molecules of 
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CMI which a re solu ble in body fluids, might be capable of 
diffusing into the stratum corneum and directly inhibiting fun-
gal proliferation. A report t hat Iymphokine containing super-
natants inhibit the in vitro growth of the yeasts Saccharomyces 
cerevisiae and Candida albicans suggests t hat lymphokine can 
have a direct effect on fun gi [6]. 
T his study uses a sensitive radiometric microassay of fungal 
growth to determine whether a Iymphokine, which in hibits t he 
growth of mouse L-929 fibroblasts, will inhibi t the growth of 
the filam entous fungus T. mentagrophytes. 
MATERIALS AND METHODS 
Organism 
Trichophyton mentagrophytes val'. granulare (American Type Cul-
ture Collection 18748 Rockville, Md.) was main ta ined on potat.o dex-
trose agar. A suspension of microaleuriospores (spores) fo r inoculum 
purposes was prepared [7]. 
Peripheral Blood Lymp hocytes 
Heparinized peripheral blood was obtained by vena puncture from 
a healthy human volunteer expressing cut.aneous delayed hyper en i-
tivity to a trichophytin antigen skin tesl. T he blood was allowed to 
sediment at 37°C for 2 hr and the plasma layer was removed. Cells 
were concentrated by centrifugation, washed 3 times with Hanks bal-
anced salt solu tion and resuspended in RPMI -1640 tissue cul t.ure me-
dium supplemented with 10% heat inactivated AB positive serum and 
4 111M I-glutamine. The cell preparation was slowly ftltered through a 
nylon wool column (10 cc syringe containing 0.8 g of nylon woo\) 
saturated with supplemented RPMI-1640 and maintained at tissue 
cul ture conditions. The colu mn was elu ted 3 times with supplemented 
medium and the resul ting cell preparation was concentrated by cen-
tri fugation. This preparation consisted of 98% small round mononucle-
ated cells, that were 95% viable as estimated by the trypan blue dye 
test. 
Lymphocyte Blastogenesis 
Lymphocytes, 1 x 10" in 200 ILl of supplemented RPMI-1640, were 
delivered to wells of a Microtest-II culture plate (Falcon, Oxnard, Ca.). 
Blastogenesis was elicited with 3 /Lg of phytohemmagglutinin-P (PHA-
P) (Difco, Detroit, Mi.) or 10 /Lg of trichophytin (Letterman Army 
Insti tute for Research, San Fralicisco, Ca.) per well. The plates were 
incubated at 37°C in an atmosphere adjusted to contain 3.5% CO2 at a 
relative humidity approaching 100%. T he cultures were pulsed 4 hI' 
before termination with 0.5 /LCi of "H-thymidine, (specific activity 25 
/LCilmmole New England Nuclear, Boston, Mass.). The DNA from 
each cul ture was precipitated on glass fil ter paper (Reeve Angel Grade 
934AH) fo llowing the procedure of Har tzman [8] using a multiple assay 
sample hal'vester (MASH) (Otto Heller Co., Madison, Wis.). T he 
recovered filter paper planchets conta ining the precipitated labeled 
DNA were subjected to liquid scintillation counting. 
Lympholline Production 
Nylon wool column purified peripheral blood lymphocytes were 
cultured in tissue cul ture tubes (Falcon 3033). Each tube contained 3 
X 10'; cells in 2.0 ml of supplemented RPMI-1640. Trichophytin (100 
/Lg) or PHA-P (30/Lg) in 100 /Ll of medium was prepared and added to 
the appropriate cul tures. Control cul tures received ]00 /Ll of medium. 
Triplicate cultures were incubated at 37°C in an atmosphere adjusted 
to conta in 3.5% CO2 at a relative humidi ty approaching 100%. At 24 hI' 
intervals stimulated and unstimulated control cultures were removed 
from the incubator and centrifuged at 150 g for 10 min. The supernatant. 
fluids from replicate cultures were carefully harvest.ed with a pasteur 
pipet, pooled and stored at -20°C. 
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Lymphohine T arget Cells 
Lymphotoxin sensitive mouse a lpha L-929 cells were obta ined from 
Dr. G. A. Granger (Scripps Clinic and Research Foundation, La J olla, 
Ca.). The cells were maintained on supplemented RPMI-1640 and 
passed every 4 days. Cells obta ined from 4-day-old main tenance cul-
tures were used in a ll Iymphokine assays. 
Lymphohine Assay 
T he method for Iymphokine assay was an adapta tion from the 
Iymphotoxin assay of Williams and Granger [9]. Two-fold seria l dilu-
tions of each Iymphokine supernatant were prepared in supplemented 
RPMI-1640. Each test dilu tion was then added in a volume of 100 III to 
replicate microtiter wells conta ining 3 x 10" mouse a lpha L-929 target 
fibroblasts in 100 ILL of supplemented RPMI-1640. Where indicated 1 
ILg of ferric iJ'on conta ined in 10 ILl of ferric ammonium cit rate solution 
was add ed. After 48 hr of incubation at tissue culture conditions, 165 
ILl of medium was wi thdrawn from the test well and replaced with 165 
ILl of PBS conta ining 0.01 % trypsin and 10- " M EoTA. Afte r 3 min the 
contents of t he well were tri turated and the cells enumerated in a 
hemocytometer. T he resul ts are re J~o r ted as the percent of growth 
inhibi tion based on growth in nonsupernatant-containing supplemented 
medium. 
Lymphohine A ntifu.ngal A ssay 
The effect of Iymphokine on the growth of T . mentagrophytes was 
est imated visua lly and measured with a sensitive automated radiomet-
ric microgrowth assay. The radiometric assay correlates fungal growth 
with the incorporation of "'C (provided as "'C (IL) glucose) into accu-
mulating trichloroacetic ac id insoluble material [10,11]. The radiomet-
ric assay was adapted for this study as follows. The glucose content of 
each lymphokine superna tant was measured and adjusted so that it 
conta ined the same amoun t of glu cose as th e fresh supplemented 
HPMI-1640. T his adjustment is necessary to assure that the fina l 
i otopic specific activity afte r the addi tion of '<l C (IL) glucose is the same 
in each superna tant. 
Two hundred microli te r aliquots of each supernatant were pipeted 
in to micro tite r wells. In to each well was pipeted 10 fLl of "'C (fL) glucose 
solution (0.1O fLC i., 4.06 mCi/mmole, New England Nuclear) and where 
indicated 1 fLg ferric iJ'on conta ined in 10 fLl of ferric ammonium citra te 
solu tion. Each well was inoculated wi th 1 x 10" spores of T. mentagro· 
p hytes in a 10 fLl volume. 
Afte r 36 hr the fungal content of each well was collec ted on fil ter 
paper (G rade 934 AH, Reeve Angel) and washed 10 times with 300 fLl 
volumes of dist illed water, 10 times wi th 300 fL l vo lumes of 5% trichloro-
acetic acid and 10 t imes with 300 fLl volumes of absolu te methanol using 
a mul tiple automated sample harvester. Fil te r paper planchets contain-
ing the washed fungus were subjected to liquid scin t illation counting to 
determine the amount of fungal growth. 
RESULTS 
Lymphocyte R eactivity 
P urified periphe ral blood lymphocytes were obtained from a 
huma n donor wit h documen ted acquired immunity to infecti on 
wit h T. mentagrophytes a nd who responded to a trichophytin 
skin test wi t h a s trong cutaneous d elayed hypersensitivity r e-
action . These cells we re test ed for the ij' capacity to undergo a 
blastogenic response to PHA-P a nd trichophytin and were used 
to produce Iy mphokine. Blas toge nesis was monjtored by the 
incorpora tion of "H-thymidine (Ta ble I). The response to tri-
chophytin increased through th e 7th and las t day of culture, 
These resul ts es t.a blish th e T -cell mitogen PHA-P and fungal 
a n t ige n reactivity of t h e donor ly mphocytes used for ge nerating 
)y mphokine. 
Lymphohine A ctivity 
Lymphokine activity was assayed by m oni toring the capacity 
to inhibi t the growt h ofly mphotoxin sens it ive L -929 fibrobl asts. 
The Figure demonstra tes t ha t the superna ta n ts from day 2 
P HA-P and day 6 trichophy tin-stimulated ly mphocy te cultures 
co ntain poten t a ctivity. The activity of these supernatants 
d ecreased linearly wi t h dilu tion . An early (day 2) trichophy tin-
s timulated cu\tUJ'e supernatan t ha d mu ch less lymphokine a c-
t ivity whi ch was not diminish ed by dilu t ion . M a ximum inhibi-
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TA BLE 1. The incOIpora.tion 0('1 H -thymidine by hu.m.an p eriphera.l 
blood lymphocytes selected for the prepamtion of lymphohine after 
stim.u.lation with PHA -P or trichophy tin" 
Time in "H· Thymidine incorporation (CPM)" 
culture (clays) Co nLrol PHA·P TrichophyLin 
2 250 ± 10 31878 ± 1011 ND 
3 404 ± 18 45293 ± 1461 3367 ± 136 
4 485 ± 35 93599 ± 2423 8009 ± 533 
5 322 ± 24 57549 ± 1071 29274 ± 875 
6 256 ± 21 43631 ± 1019 39209 ± 1274 
7 270 ± 19 ND 51498 ± 1758 
" 1 x 10" nylon wool column purified lymphocytes were cultured in 
200 JlI volumes and harvested with a MASH on the indicated day after 
ini t iation of the cul ture. 
/> Each value is the mean of 6 replicate cul tures plus or minus the 
standard deviation. NO means not determined. 
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FIG 1. Lymphokine activity of supernatan ts tested for antifungal 
ac tivi ty. Lymphokine was assayed by the capacity to inhibit the growt h 
of Iymphotoxin sensitive mouse L-929 fibroblasts. Each p oint is the 
mean of 4 replicate assays each of which va ries no more t.han 5% from 
the mean. 
t ion of L-929 fibroblas t growth (74% with t h e day 2 PHA-P and 
85% with the day 6 trichophytin superna tants ) occurred a t a 1: 
2 dilution . The Iy mphokine activity of control superna tants 
(uns timulated) n ever exceed ed 10%. 
Antimycotic A ctivity of Lymphohine 
Lymphokine containing superna ta nts wer e t ested for their 
capacity to inhibi t the growth of' T . mentagrophy tes. B efore 
assaying for a ntimycotic activi ty, ferric iJ'on (1 Jlg / ml of super-
natant) was added to saturate the iron binding capacity of the 
tra nsferrin in the m edium since iron unsatUl'ated transferrin 
will inhibit the growth of T . mentagrophytes [12]. Fungal 
growth in undiluted nonlymphokine containing control super-
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natants was no t visually differen t from fun gal growth in undi-
luted superna ta nts (day 2 PHA-P and day 6 t richophytin ) with 
d e monstrated lymphokine activ ity. These visual observations 
w e re confirmed using a sensitive radiometric fungal growth 
a s s ay (Ta ble II). The incorpora tion of I"C into new accumulat-
ing mycelia was not inhjbited by the presence of lymphokine. 
In order to test th e possibili ty that the addition of ferric iron 
t o lymphokine abrogated its activity, the day 2 P HA-P and day 
6 t richophytin superna tants were supplemented with iron and 
reassayed for growth inhibi tory activity aga inst mouse L-929 
fibrobl asts. The da ta from this experiment a re presented in 
Table III and indicate t hat the addition of 1.0 ,ug/ml of ferric 
iron which is sufficien t to saturate the il'on binding capacity of 
the contained transferrin did no t destroy Iymphokine mediated 
growth inrubitory activity for mouse L-929 fibroblasts. 
Lymphokine with and without the il'on supplement were next 
tested for t heir capacity to inhibi t the growth of T . m entagro· 
phy tes. Table IV demonstt:at~s that iron unsupplemented l y~­
phokine s uperna tan ts as dJd fresh serum supplemented medJa, 
did not allow fun gal growth beyond germination which is indio 
cated by the minimal fungal incorpora tion of I'IC « 300 cpm). 
In contrast supplementation with ferric iron permitted profuse 
funga l growth which is consistent with the negation of t ransfer · 
rin media ted fungal inhibitory activi ty by iron saturation. 
SupernaLant. 
co ll ected at 
t ime (days) 
1/ 4 
2 
6 
funga l growt h (CPM "'C) I, 
Control PHA· P T richophytin 
9644 ± 71 8 9969 ± 294 94 89 ± 549 
9549 ± 401 10078 ± 745 9779 ± G37 
8011 ± 1473 ND 7G22 ± 1320 
" AU superna tants were adjus ted to conta in 1.63 m g/m l of glucose. 
2 00/-11 of the indicated supernatant was placed in to wells of a microtiter 
plate, supplemented wi th O.lllCi of '''C(Il ) glucose, 1.0 Ilg of ferric ir on 
a nd inocu lated wi th 1 X 10" spores of T. menlagrophyles . 
b Each va lue is the mean of 4 replicat.e cul tures plus or minus t.he 
standm'd devia tion. N D means not determined. 
TAB L E III. The effeci of ferric iron on the aclivily of lymphohine 10 
inhibil Ih e growth of mOllse L·929 fibroblaslS 
Day 2 PHA·P Duy 6 trichophytin 
S upernata nt 
1.0 J.l.1l 1.0 I'll dilution No Fe'l:! No Fe' :! Fe"'/ Inl Fe1 :'/ ml 
[:2 86" 97 78 74 
1:4 72 84 69 62 
1:8 G9 55 5 1 54 
1: 16 G8 45 42 44 
1:32 45 38 25 2G 
1:64 34 18 17 14 
l :128 28 15 ]() 8 
" Lymphokine activity is reported as the percent growth inhibit ion 
b ased on growth in fresh media. Each va lue is the mean of 3 replica te 
assays each of which varied no more tha n 5% from the mean. 
TABLE IV. The effeci of ferric iron 0 11 the capacity of lYlllpholiill e 
containing ;;l.Ipernatan.ts 10 inhibit Ihe grOllltll of T . menlagropllyles." 
S upernat.a nt 
P HA·P Day 2 
Trichophytin Day 6 
F J'esh media 
Fun~n l growLh (CPM "'C)" 
No Fe' " 
183 ± 42 
275 ± 11 
158 ± 12 
8078 ± 317 
7700 ± 9 14 
10295 ± 1440 
" All supernatan ts were adjusted Lo co nla in 1.63 mg/ ml of glucose. 
200 III of the indicated supernatant Or media supplemented with 10% 
huma n serum was placed in to wells of a microl ite r plate, supplemen'ted 
wi th 0.1 )lCi of ' ''e (f L) glucose, iron as indicat.ed and inoculated wi th 1 
X 10" spores of T. menlagrophytes. 
b E ach va lue is the mean of 4 replica te cul tures plus Or minus t.he 
standard devia tion. 
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These data indicate that Iymphoki ne capable of inhibiting 
t he growth of mouse L·929 fi brob lasts does not inhibi t the 
growth of the fil amentous fungus T . mentagrophytes. 
DISCUSSION 
Lymphokine was prepa red by stimulating lymphocytes with 
P HA-P and the fun gal an tigen trichophy tin . T his Iymphokine 
al t hough not purified or concentrated, had potent mammalian 
cell growth inhibi tory activity when assayed against mouse L-
929 fibroblasts (Figure) . 
Lymphokine containing supernatants and fresh t issue culture 
medium supplemented with serum inhibited t he growth of T. 
mentagroplzy tes (T a ble I V). T his inhi bition of fu ngal growth 
was negated by the addi t ion of fe rric iron which, however, did 
not diminish the lymphokine activity for mouse L·929 fibro-
blasts (Ta ble III). S ince both the lymphokine containing super· 
natants and the freshly prepared serum supplemented mediu m 
inhibi ts fungal growth , t he activity is most likely accoun ted fo r 
by the presence of iron unsaturated transferrin from the seru m 
supplement. Neither il'on saturated nonlymphokine containing 
control or Iymphokine conta in ing supernat.ants inhibi ted fu ngal 
growth indica ting that Iymphokine active against L-929 fibro-
blasts does not inhibit t he growth of the filamentous fu ngus T. 
mentagrophytes (Table II) . 
. Th ese findin gs differ from those of Pearsall , Sundsmo, and 
Weiser [6] who repor ted that supernatants fro m cul tures of 
allogenic mouse spleen cells stimulated with PH A-P for 2 days 
inhibits the growth of th e yeast.s S. cerevisiae and C. albicans. 
This apparent discrepancy may be expla ined in several ways. 
FiJ'st, theil' supernatants and ours conta ined transferrin fro m 
a JO% serum supplement . Unlike Ours the iron binding capacity 
of the transferrin in theil' supernatants was not saturated. T hat 
unsa turated transferrin can exer t a pot.ent fun gal growth inhib· 
itory effect against T. men.tagrophy tes and to a lesser extent C. 
a.lbicans by the deprivation of iron has been reported [12,13]. 
This leads to the in teresting possibili ty t hat a fungal growth 
inhibi tory factor t hat is an iron chelator similar to t ransferrin 
or lactoferrin is secreted by activated lymphocytes. A chelator 
released from activated lymphocytes could account for the 
difference in activity of the control compared to Iymphoki ne 
supernatant in t he study of Pearsall , Sundsmo, and Weiser [6]. 
Consistent with this idea is the repor t t hat human lymphocytes 
can synthesize transferrin (1 4]. Whether lymphocyte produce 
and excrete transferrin capa ble of inhibit ing fun gal growth is 
not known. 
Second, Iymphokine may inhibi t t he growth of yeasts but not 
filamento us fun gi due to the biochemical and structura l di ffe r-
ences between yeasts and fil amentous fungi. 
Although the present study does not provide support for the 
antimycotic activity of lymphokine, add itiona l stud ies in which 
Iymphokine is pur ified and concent rated before testing for 
ant imycotic activity ar e needed. That the Iymphokine cont.ent 
of our supernatants is significantly less than that achieved in 
vivo at the site of a cutaneous CMI inflammatory reaction is 
also possible. We have, however, inoculated microcul tures of 
both P HA-P and trichophytin activated human lymp hocytes 
wi th the spores of T. mentagrophytes, supplemented t hese 
cul tures with ferric iron, and microscopically monitored fungal 
growth. Under these condi t ions the an timycotic effect of lym -
phocytes or theil' nonchela tor products should be maxima l. We 
found tha t t here was no microscopically detectable inhibition 
of fungal growth. 
It is Olll' contention that lymphocytes or t heil' products (lym-
phokine) other than chela tors do not act d irectly on the fungus 
bu t may act indirectly aga inst some host component, possibly 
epidermal cells, during a dermatophyte in fect ion [1]. T he inhi · 
bition of L-929 fibroblast growth by t ri chophytin elicited Iym· 
phokine is consistent wi th t his t heory as is t he report of in · 
creased epidermal proliferation at the site of a cuta neous de-
layed hypersensit ivity reaction elicited by funga l antigen [1 5]. 
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Announcement: Program Research Interests in Immune Mechanisms and 
Cutaneous Disorders (immunodermatology), National Institute of Allergy 
and Infectious Diseases 
The National Institute of Allergy and Infectious Diseases is interested in expanding research activities 
of the Immunology, Allergic, and Immunologic Diseases Program concerned with immune mechanisms 
and hypersensitivity reactions in diseases of the skin . The purpose of this announcement is to encourage 
the in teraction of researchers in all ergy, dermatology, and imm unology in orde]· to adva nce progress in 
the preven tion, diagnosis, and treatment of immune-mediated skin diseases. Some areas encompassed by 
the scope of this program include investigations designed to study allergic phenomena and immune 
mechanis ms in the following condit ions: 
1. studies to differentiate allergic skin disorders arising as a result of IgE related mechanisms: cell-
mediated immunity/ delayed hypersensitivi ty, and inflammation emerging fTom activation of the comple-
ment cascade and the effects of chemical mediators. 
2. atopic dermatitis: the definition of possible interacting etiologies that influence the development and 
course of allergic eczema as a multifactorial disorder; 
3. urticaria and angioedema: investigations to detect and define the multiple allergenic, neurogenic, 
chemical, and microcu'culatory factors that result in heterogeneous disorders with identical presentation; 
4. contact hypersensitivity: evaluation of the nature of normal skin cell components converted to 
antigenic determinants as a result of in teraction with sens itizi ng agents; 
5. infection: immune responses to both pathogenetic and saprophytic fl ora serving as microbial antigens 
in immune and hypersensitivity reactions. 
For fUl'ther information investigators are encouraged to contact: 
Robert A. Goldstein, M.D., Ph .D . 
Chief, Allergy and Clinical 
Immunology Branch 
National Institute of Allergy and 
Infectious Diseases 
Room 755, Westwood Building 
Bethesda, Maryland 20205 
Telephone: (301) 496-7104 
In order to a lert the Skin Diseases Program of the NIAMDD to the submission of proposals with 
primary thrust directed to dermatology, you may wish to communicate with: 
Laurence H . Miller, M.D. 
Director, Skin Diseases Program 
Extramural Programs 
National Institute of Arthritis, 
Metabolism, and Digestive Diseases 
Room 405, Westwood Building 
Bethesda, Maryland 20205 
Telephone: (301) 496-7326 
